Allopurinol Tablet
Product Images NDC 43063-934

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 43063-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063934 Label (43063934)

This is a description of a medication named Allopurinol, USP. Each tablet has 300 mg of Allopurinol. It is marketed and packaged by PD-Rx Pharmaceuticals, Inc. The usual dosage is not specified, but the full prescribing information is available on the package. The medicine should be kept in a cool and dry place, between 20° to 25°C (68° to 77°F). The prescribed medication should be kept in a tight, light-resistant container out of reach of children. It is recommended to read the package for complete instructions. The medicine is available in a pack of 100 tablets with an expiry date of 09/2021.*

FDA Label Image

Structure (Allopurinol 01)

FDA Label Image

Figure (Allopurinol 02)

Allopurinol and Oxipurinol are chemical compounds that belong to the family of pyrimidines and purines. They are commonly prescribed to reduce the production of uric acid in the body, which can cause gout and kidney stones. The chemical structures of Allopurinol and Oxipurinol contain dibydro-4Hpyrazolo, H-pyrazalo, and 3,4-0 yrimidin-d-one pyrimidine, 4.6 (SH,7H)-dione. They work by inhibiting the enzyme responsible for the conversion of hypoxanthine and xanthine to uric acid. Their use can help reduce the symptoms of gout and prevent kidney stone formation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.